For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Atyr Pharma Inc (NASDAQ: ATYR) was $3.91 for the day, up 8.01% from the previous closing price of $3.62. In other words, the price has increased by $8.01 from its previous closing price. On the day, 1.4 million shares were traded. ATYR stock price reached its highest trading level at $3.97 during the session, while it also had its lowest trading level at $3.63.
Ratios:
Our analysis of ATYR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 04, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 24 ’24 when SCHIMMEL PAUL bought 52,300 shares for $1.93 per share. The transaction valued at 101,038 led to the insider holds 413,023 shares of the business.
SCHIMMEL PAUL bought 41,052 shares of ATYR for $71,500 on Jul 22 ’24. The Director now owns 354,075 shares after completing the transaction at $1.74 per share. On Jul 23 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 6,648 shares for $1.82 each. As a result, the insider paid 12,075 and bolstered with 360,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 328214784 and an Enterprise Value of 275611808. For the stock, the TTM Price-to-Sale (P/S) ratio is 1427.01 while its Price-to-Book (P/B) ratio in mrq is 4.54. Its current Enterprise Value per Revenue stands at 1172.816 whereas that against EBITDA is -4.093.
Stock Price History:
Over the past 52 weeks, ATYR has reached a high of $3.98, while it has fallen to a 52-week low of $1.39. The 50-Day Moving Average of the stock is 19.45%, while the 200-Day Moving Average is calculated to be 77.93%.
Shares Statistics:
ATYR traded an average of 1.05M shares per day over the past three months and 963010 shares per day over the past ten days. A total of 83.94M shares are outstanding, with a floating share count of 81.96M. Insiders hold about 2.36% of the company’s shares, while institutions hold 63.01% stake in the company. Shares short for ATYR as of 1734048000 were 2920070 with a Short Ratio of 2.78, compared to 1731628800 on 2114376. Therefore, it implies a Short% of Shares Outstanding of 2920070 and a Short% of Float of 4.58.
